Publications

Biosimilar approval pathways: comparing the roles of five medicines regulators.

J Law Biosci
Knox RP, Desai V, Sarpatwari A

Biosimilar Uptake In The US: Patient And Prescriber Factors.

Health Aff (Millwood)
Hong D, Kesselheim AS, Sarpatwari A, Rome BN

Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.

JAMA Netw Open
Feldman WB, Mahesri M, Sarpatwari A, Huybrechts KF, Zhu Y, Hwang CS, Lii J, Lee SB, Kattinakere Sreedhara S, Toyserkani GA, Zhou EH, Zendel L, LaCivita C, Manzo C, Dal Pan GJ, Kesselheim AS, Bykov K